Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.

Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer. Am J Clin Oncol. 2015 Dec; 38(6):605-9.

View in: PubMed

subject areas

Adenocarcinoma
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Chemoradiotherapy
Chest Pain
Cohort Studies
Cough
Dyspnea
Esophagitis
Etoposide
Female
Hemoptysis
Humans
Lung Neoplasms
Male
Middle Aged
Paclitaxel
Palliative Care
Pemetrexed
Radiation Injuries
Radiation Pneumonitis
Retrospective Studies
Treatment Outcome

authors with profiles

Mary Fidler
Marta Batus